Tag: USFDA
Zydus Lifesciences gets FDA green light for acne treatment gel
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) for its Clindamycin Phosphate Gel USP, 1%. With annual ... Read More
Granules India subsidiary completes FDA PADE inspection with zero observations
Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of Granules India Limited, situated in Chantilly, Virginia, USA, has successfully concluded the United States Food ... Read More
FDA approves Janssen’s TECVAYLI for multiple myeloma treatment
The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration's approval of its first bispecific T-cell engager antibody, ... Read More
Zydus Lifesciences gets final FDA approval for Mirabegron generic
Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More
Lupin Limited launches Generic Suprep Bowel Prep Kit in the US
Indian pharma company Lupin Limited has launched Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, after getting ... Read More
Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US
Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More